Brief: Innoviva Announces FDA Advisory Committee Meeting To Review Sulbactam-Durlobactam (Sul-Dur), An Investigational Targeted Antibiotic

Innoviva

13/03/2023 22:26

March 13 (Reuters) - Innoviva Inc  INVA.O :
    * INNOVIVA ANNOUNCES FDA ADVISORY COMMITTEE MEETING TO
REVIEW
SULBACTAM-DURLOBACTAM (SUL-DUR), AN INVESTIGATIONAL TARGETED
ANTIBIOTIC
    * INNOVIVA INC: ADVISORY COMMITTEE WILL CONVENE APRIL 17,
2023 TO
REVIEW DATA SUPPORTING NEW DRUG APPLICATION (NDA) FOR
SULBACTAM-DURLOBACTAM

Source text for Eikon:  ID:nBw9JKYKPa 
Further company coverage:  INVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))